Slide 1: Q1 2023 Results
-_< Q1 2023 Results Brenntag SE May 10, 2023 BRENNTAG
Slide 2: 1. Highlights Q1 2023
Q1 2023 Results 1. Highlights Q1 2023 Presentation
Slide 3: Highlights Q1 2023
Highlights Q1 2023 SALES EUR 4,527m -1.0% vs. PY (fx adj.) FREE CASH FLOW ~EUR 449m More than 9x the prior-year level OPERATING GROSS PROFIT EUR 1,046m -0.3% vs. PY (fx adj.) SHARE BUYBACK Execution progressing well Buyback started in March 2023 OPERATING EBITA EUR 345.1m -13.1% vs. PY (fx adj.) Hor
Slide 4: Brenntag continued to manage challenging macroeconomic conditions well in Q1 2023
Brenntag continued to manage challenging macroeconomic conditions well in Q1 2023 = Macroeconomic environment continued to be challenging * Brenntag benefitting from high diversification in product portfolio and supplier base * Geopolitical uncertainties and strong inflationary trends = Better perfo
Slide 5: Brenntag to host a Capital Markets Day in autumn to provide an update on Horizon 2
Brenntag to host a Capital Markets Day in autumn to provide an update on Horizon 2 - “ Strategy to win” Horizon 2 - “Strategy to win” “Strategy to Win” represents the second phase in Brenntag’s successful transformation Fostering increasing independence of BES and BSP and aiming to a: lerate sustain
Slide 6: 2. Financial performance Q1
Q1 2023 Results Presentation 2. Financial performance Q1 2023
Slide 7: Operating EBITA bridges
Financials Q1 2023: Operating EBITA bridges” Reconciliation - Operating EBITA growth (FX-adj.) inEURm sh -13% J Ql 2022 3 = -54 FX translation M&A Organic contribution growth FX translation A7 QL 2023 Hl M&A contribution Segment - Operating EBITA growth (FX-adj.) inEURm +3% -13% | Loa Ql 2022 Brennt
Slide 8: Brenntag Specialties
Financials Q1 2023: Brenntag Specialties Operating EBITA growth”) EMEA AMERICAS -24.3% -19.5 % Focus industries (GP dev.) Nutrition APAC -42.3% Pharma Personal Care/HI&l Water treatment SD Se/DS Material Science Lubricants 77 () 8 1) Growthrates are adjusted for translational FX-effects Brenntag Spe
Slide 9: Brenntag Essentials
Financials Q1 2023: Brenntag Essentials Operating EBITA growth”) EMEA LATIN AMERICA +10.9% -38.5 % NORTH AMERICA APAC +11.8% - 74.6 % G 9 “Growth rates are adjusted for translational FX-effects Brenntag Essentials showed a strong performance and achieved encouraging growth in Q1 2023 Op. Gross Profi
Slide 10: Income statement
Financials Q1 2023: Income statement in EUR m Q1 2023 Sales 4,527.1 Cost of materials -3,481.5 Operating expenses 625.2 Depreciation -76.3 Net income / expense from sp. items AT Amortization AT Financial result -35.2 EBT 296.9 EPS 1.40 ® 10 Q1. 2022 4,633.1 -3,495.2 1,087.9 -674.9 463.0 68.7 394.3 -
Slide 11: Free cash flow
Financials Q1 2023: Free cash flow in EURm Operating EBITDA Payments to acquire intangible assets and property, plant and equipment A Working capital) Principal and interest payments on lease liabilities Free cash flow () 11 Based on average fx. rate excl. M&A 2023 420.4 -49.7 116.7 -38.2 449.2 Ql 2
Slide 12: Working capital
Financials Q1 2023: Working capital in EURm 31 Mar 2023 BME ely} Inventories 1,661.8 + Trade receivables 2,693.1 ./. Trade payables 1,902.0 Working capital turnover (annualized)) 7.2x a » Based on fx. effects as of end of respective reporting period and incl. M&A 12 1,773.8 2,676.8 1,862.0 2,588.6 7
Slide 13: Balance sheet and maturity profile
Financials Q1 2023: Balance sheet and maturity profile in EURm RXR CeteeyXE 31 Dec 2022 in EUR m Financial liabilities 2,665.9 2,661.5 ESG- linked ° Eurobond & SSD gynd. Loan Lease liabilities 462.1 434.3 Eurobond & SSD ./. Cash and cash equivalents 844.7 1,046.1 724 SsD Net Debt 2,283.3 2,049.7 416
Slide 14: 3. Outlook
Q1 2023 Results Presentation 3. Outlook
Slide 15: Outlook 2023: Well positioned in a continuously challenging environment
Outlook 2023: Well positioned in a continuously challenging environment Operating © EBITA Guidance [ [ i Comments Macro environment 1 Additional information FY 2023 operating EBITA guidance of EUR 1.3-1.5bn confirmed This is equivalent to an operating EBITDA of EUR 1.6-1.8bn Guidance includes the po
Slide 16: Christian Kohlpaintner CEO, Kristin Neumann CFO
Christian Kohlpaintner Kristin Neumann CEO CFO
Slide 17: 4. Appendix
Q1 2023 Results Presentation 4. Appendix
Slide 18: Segments (1/2)
Financials Q1 2023: Segments (1/2) inEURm Operating Gross Profit) Brenntag Specialties 388.2 Brenntag Essentials 648.1 AllLother segments 9.3 Brenntag up. 1,045.6 426.2 602.9 8.8 1,037.9 inEURm Operating EBITA ER = Q12022 Brenntag Specialties 153.0 Brenntag Essentials 224.3 AllLother segments -32.2
Slide 19: Segments (2/2)
Financials Q1 2023: Segments (2/2) in EURm Operating Gross Profit Operating EBITA® Conversion Ratio 2023 Jaeretyy) A adjusted Peg © 12022 A adjusted 2023 iermtyr) Specialties EMEA 178.4 195.0 85% 6.7% 749 1010 -25.8% —-24.3% 420% 51.8% Specialties Americas 1449 1875 80% 112% 56.0 661 168% -195% 38.0
Slide 20: Cash flow statement
Financials Q1 2023: Cash flow statement in EURm Q1 2023 Q1 2022 Profit after tax 217.1 254.0 Effect from IAS 29 on profit/loss after tax 27 - Depreciation & amortization 93.0 86.9 Income tax expense 79.8 94.7 Income taxes paid -36.9 477 Net interest expense 27.2 18.2 Interest paid (netted against in
Slide 21: Cash flow statement (continued)
Financials Q1 2023: Cash flow statement (continued) in EURm Proceeds from the disposal of other financial assets Proceeds from the disposal of intangible assets and property, plant and equipment Payments to acquire consolidated subsidiaries and other business units Payments to acquire intangible ass
Slide 22: Financial calendar / contact
Financial calendar / contact ~ Date Event May 10, 2023 Interim Report Q1 2023 Brenntag SE June 15, 2023 General Shareholders’ Meeting Corporate Investor Relations Phone: +49 (0) 201 6496 2100 Fax: +49 (0) 201 6496 2003 August 9, 2023 Interim Report Q2 2023 E-mail: ir@brenntag.de Web: www.brenntag.co
Slide 23: Disclaimer
Disclaimer This presentation may contain forward-looking statements based on current assumptions and forecasts made by Brenntag SE and other information currently available to the company. Various known and unknown risks, uncertainties and other factors could lead to material differences between the